REPEAT – Nabis Holdings Announces Investment Into Hivemind Refinery (“HIVEMIND”) – an Established CBD Wellness Product Line
HIVEMIND CBD Line to Be Distributed Across United States & Canada THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. […]
Priority Review Granted to Zai Lab’s NDA Application for ZEJULA (Niraparib) in China
SHANGHAI, China, Jan. 28, 2019 (GLOBE NEWSWIRE) — Zai Lab Limited (NASDAQ: ZLAB), a China and US-based innovative commercial stage […]
BioReference Laboratories Supports Federal Employees Amidst Government Shutdown
Elmwood Park, New Jersey, Jan. 28, 2019 (GLOBE NEWSWIRE) — BioReference Laboratories Inc., an OPKO Health Company (NASDAQ: OPK), today […]
Macatawa Bank Corporation Declares Quarterly Dividend
HOLLAND, Mich., Jan. 28, 2019 (GLOBE NEWSWIRE) — Macatawa Bank Corporation (Nasdaq: MCBC) (the “Company” or “Macatawa”) today announced that […]
Conatus Pharmaceuticals Announces Publications Expanding on Previously Reported Results from Completed Phase 2 NAFLD-NASH, Portal Hypertension and Liver Cirrhosis Clinical Trials
SAN DIEGO, Jan. 28, 2019 (GLOBE NEWSWIRE) — Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced publications expanding on previously reported results […]
TSX News -
Helix BioPharma Corp. Extends Annual Meeting Date
RICHMOND HILL, Ontario, Jan. 28, 2019 (GLOBE NEWSWIRE) — Helix BioPharma Corp. (TSX, FSE: “HBP”) (“Helix”), an immuno-oncology company developing […]
VitalHub Announces licensing of TREAT and B Care solutions to the Government of Yukon to improve the management and treatment of Mental Wellness and Substance Use across the Territory
TORONTO, Jan. 28, 2019 (GLOBE NEWSWIRE) — VitalHub Corp. (the “Company”) (TSXV: VHI) is pleased to announce the sale of […]
Medtronic Announces U.S. Commercial Launch of Mazor X Stealth(TM) Edition for Robotic-Assisted Spine Surgery
First U.S. Patients Treated Using Mazor X Stealth(TM) Edition at Norton Healthcare and Reston Hospital Center DUBLIN – January 28, […]
XORTX to Present at NobleConXV Noble Capital Markets’ 15th Annual Investor Conference
CALGARY, Alberta, Jan. 28, 2019 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (CSE:XRX; OTCQB:XRTXF), a biopharmaceutical company […]
Quinsam Announces Dividend & Corporate Update
Westleaf Has a Very Strong Trading Debut NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION BY ANY UNITED […]
